FDA Brief

Warning letters Drugs

FDA warning letter to

K.C. Pharmaceuticals, Inc.

High riskIssued Aug 12Posted Aug 18Center for Drug Evaluation and Research (CDER)

FDA cited K.C. Pharmaceuticals of Pomona, CA, for sterile-drug manufacturing failures, including aseptic practice problems and failed media fills.

What happened

FDA inspected the K.C. Pharmaceuticals drug manufacturing facility in Pomona, CA, from January 20 to February 13, 2026. Investigators found the company kept making and releasing sterile drugs after its media fills (test batches made with growth medium instead of drug, used to prove the filling line stays sterile) failed on June 21, September 4 and November 4, 2024, and that operators breached the sterile barrier during filling. FDA also found inadequate airflow (smoke) studies, visual inspection that could not catch particles in the product, missing stability-indicating test methods, lab testing done without first checking the instruments worked, and weak quality-unit handling of complaints and stability testing.

What FDA found

  1. The company had no adequate written procedures to prevent microbiological contamination of its sterile drugs, and it continued to make and release sterile products after media fill failures without timely, well-supported investigations or effective corrective actions.

    21 CFR 211.113(b)
  2. Operators in the cleanest (ISO 5) filling areas leaned into the barrier system, handled parts without forceps and opened the barrier to reach difficult spots, and the company did not investigate what impact this had on the sterility of drugs already sold; its airflow (smoke) studies also could not show that air flowed correctly.

    21 CFR 211.113(b)
  3. The visual inspection after filling was not good enough to find particles and foreign matter in every unit, and its sampling plan did not even include a defect category for particulates.

    21 CFR 211.100(a)
  4. The company had not established stability-indicating test methods for its OTC products, so it could not show that test results stayed accurate over the product's shelf life.

    21 CFR 211.166(a)
  5. The lab ran total organic carbon and conductivity tests without first checking that the analyzer was performing suitably for that day's testing.

    21 CFR 211.160(b)
  6. The quality unit's written procedures were inadequate and not followed: complaint severity was judged by who complained rather than by risk, investigations were late or incomplete, and stability time points and tests were missed.

    21 CFR 211.22(d)

What FDA wants

FDA asks for an action plan covering product quality and patient safety risks for the company's drugs in U.S. distribution, including possible customer notifications and recalls, plus independent assessments, contamination-hazard risk assessments, and corrective action plans for aseptic operations, visual inspection, stability testing, laboratory controls and the complaint system. The letter does not state a response deadline in the text provided.

Who should pay attention

  • companies whose OTC products are made at this contract manufacturer
  • distributors and retailers selling the affected OTC drug products
  • other aseptic fillers that rely on media fills and smoke studies for sterility assurance

This is a summary. Read the original letter on fda.gov.

K.C. Pharmaceuticals, Inc.'s FDA history

  1. K.C. Pharmaceuticals Inc.

    CGMP/Finished Pharmaceuticals/Adulterated

Recalls in the last 12 months

Oct 14 Class II K.C. Pharmaceuticals, Inc.
Drug
Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, www.myleader.com, NDC 70000-0502-1; b) Crocodile Tears, Distributed by: Crocodile Tears, Palm …
Lack of Assurance of Sterility
Oct 14 Class II K.C. Pharmaceuticals, Inc.
Drug
Sterile EYE DROPS Advanced Relief, (dextran 70, 0.1%, polyethylene glycol 400 1% and tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) bottles, Sterile; a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, www.myl…
Lack of Assurance of Sterility
Oct 14 Class II K.C. Pharmaceuticals, Inc.
Drug
Sterile Eye Drops, ORIGINAL, Tetrahydrozoline HCl 0.05% Redness Reliever ¿ Fast Acting Formula) Product size: 0.5 fl oz (15 mL); a) Best Choice, PROUDLY DISTRIBUTED BY: VALU MERCHANDISERS, CO., 5000 KANSAS CITY, KS 661…
Lack of Assurance of Sterility
Oct 14 Class II K.C. Pharmaceuticals, Inc.
Drug
Sterile High Performance Ultra Lubricating Eye Drops (Polyethylene Glycol 400, 0.4% Relieves Dry and Irritated Eyes) Product size: 0.5 fl oz (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, www.m…
Lack of Assurance of Sterility
Oct 14 Class II K.C. Pharmaceuticals, Inc.
Drug
Eye Drops MAXIMUM, REDNESS RELIEF, Sterile, 1/2 FL OZ (0.5 ML); a) exchange select, Manufactured for your Military Exchange By: K.C Pharmaceuticals, Inc., Pomona, CA 9176, UPC: 6 14299 89636 9; b) Harris Teeter, PROUDLY …
Lack of Assurance of Sterility
Oct 14 Class II K.C. Pharmaceuticals, Inc.
Drug
Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15 mL) bottles; a) Best Choice, PROUDLY DISTRIBUTED BY: VALU MERCHANDISERS, CO., 5000 KANSAS CITY, KS 66106, UPC 0 70038 47…
Lack of Assurance of Sterility
Oct 14 Class II K.C. Pharmaceuticals, Inc.
Drug
Sterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl. oz. (15 mL) bottles; a) Equaline, DISTRIBUTED BY: UNFI, PROVIDENCE, RI 02908 UPC 0 41163 25114 4; b) Good Sense Sterile Eye Drops, Distribute…
Lack of Assurance of Sterility
Oct 14 Class II K.C. Pharmaceuticals, Inc.
Drug
Sterile Eye Drops Redness Relief (Glycerin 0.25%, Naphazoline HCl 0.02% Lubricant | Redness Reliever) (Relieves Dryness, Burning and Irritations), 0.5 fl oz (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, …
Lack of Assurance of Sterility
Apr 8 Class II K.C. Pharmaceuticals, Inc
Drug
Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15 mL) bottles; a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, www.myleader.com, NDC 70000-0011-1; b) Good …
Lack of Assurance of Sterility
Apr 8 Class II K.C. Pharmaceuticals, Inc
Drug
Ultra Lubricating Eye Drops (polyethylene 400 0.4%, propylene glycol 0.3%), Sterile, 0.5 FL OZ (15mL) bottles; a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, www.myleader.com, NDC 70000-0457-1; b) Harris …
Lack of Assurance of Sterility
Apr 8 Class II K.C. Pharmaceuticals, Inc
Drug
Sterile Eye Drops ORIGINAL FORMULA (tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15mL) bottles; a) Good Sense Sterile Eye Drops, Distributed By: Perrigo Direct, Inc., Peachtree City, GA 30269, www.PerrigoDirect.com, NDC 50804…
Lack of Assurance of Sterility
Apr 8 Class II K.C. Pharmaceuticals, Inc
Drug
Dry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene glycol 400 1%) 0.5 FL OZ (15 mL) bottles; a) GERI CARE, Distributed by: Gericare Pharmaceuticals Corp., Lakewood, NJ 08701, NDC 57896-181-05; …
Lack of Assurance of Sterility
Apr 8 Class II K.C. Pharmaceuticals, Inc
Drug
Sterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012%), 0.5 fl oz (15 mL) bottles; a) Industrial Eye Relief, Distributed by: Cintas Corp., Mason, OH 45040, UPC 130209; b) Good Neighbor Pharmacy E…
Lack of Assurance of Sterility
Apr 8 Class II K.C. Pharmaceuticals, Inc
Drug
EYE DROPS Advanced Relief, (dextran 70 0.1%, polyethylene glycol 400 1% and tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) bottles, Sterile; a) Walgreens, DISTRIBUTED BY: WALGREEN CO., DEERFIELD, IL 60015; UPC 3 11917 …
Lack of Assurance of Sterility
Apr 8 Class II K.C. Pharmaceuticals, Inc
Drug
Sterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl. oz. (15 mL) bottles; a) Best Choice, PROUDLY DISTRIBUTED BY: VALU MERCHANDISERS, CO., 5000 KANSAS AVE, KANSAS CITY, KS 66106, UPC 0 70038 470…
Lack of Assurance of Sterility
Apr 8 Class II K.C. Pharmaceuticals, Inc
Drug
STERILE EYE DROPS SOOTHING TEARS (polyethylene glycol 400 0.4% and propylene glycol 0.3%), 0.5 OZ 0.5 fl oz (15 mL) bottles; a) Rugby LUBRICATING EYE DROPS, Distributed by: Rugby Laboratories, Livonia, MI 48152, NDC 053…
Lack of Assurance of Sterility

Full company page

Similar letters to other companies

  1. Hanlim Pharm Co., Ltd.

    FDA warned Hanlim Pharm over serious sterile manufacturing violations, including poor aseptic practices and airflow problems, at its South Korea plant.

    High risk
  2. Sciarra Aeromed, Inc.

    Sciarra Aeromed's purportedly sterile veterinary drug was contaminated and made under insanitary conditions, FDA says.

    High risk
  3. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warned Empower Pharmacy over unapproved compounded semaglutide/tirzepatide copies and sterile manufacturing deficiencies that put patients at risk.

    High risk
  4. Bausch & Lomb Inc.

    FDA warns Bausch & Lomb of persistent microbial contamination and poor aseptic controls at its Tampa sterile drug plant.

    High risk